Skip to main content
Unlike a lot of other companies, we rarely spin up job posts or advertising campaigns. Instead, we built a robust knowledge graph covering every medical expert and PhD in the US, and most of the popular countries abroad. We currently track over 40M experts worldwide. To build this network, we used over a hundred data sources. For instance, for medical experts in the US, we look at:
  • Their education — institution, faculty, and program. We assign a tier to each parameter, based on the public information, prestige, and what it takes to graduate.
  • Work history — we maintain a detailed work history for experts: where they started, where they work now, how long they’ve been working, how many patients they saw, what kind of patients, and what’s the distribution for conditions. Workplaces are also assigned tiers.
  • Scientific contribution — we check if they’ve published any articles, if those articles were published in peer-reviewed journals and which exact journals, along with a tier of a publication. We track their citation number and H-index. We cross-reference it with their peers and associated institutions and labs to confirm that it wasn’t a one-shot but a steady workstream for them.
  • References — we check what their colleagues and/or patients say about them.
  • Licenses/training — monitoring their NPI and state-level licenses gives us a strong indication if an expert meets the high standards.
  • Languages they speak — we check their public information and country of education/work to ensure they speak the language that’s needed for a given project.
  • Other work — in certain cases, we monitor if an expert participated in any kind of trials (relevant for oncology/therapeutic domains), or if they obtained funding through the NHS or other governmental programs.
All combined, we use about 30 data sources in the US and over 100 globally to source the right expert for the job. Once an expert is found, we run a targeted and scalable headhunting campaign, allowing us to staff experts within days. Where sometimes vendors struggle to find an oncologist with a GLP-1 trial who speaks both English and German — we can do that. Same goes for life-science experts. We don’t just staff any biology PhD; we find the biology post-doc from Stanford who worked on a very specific small molecule and has a proven track record in the field. In certain cases, where the price that an expert asks is too high, we use a combination of international experts with a review layer selected from top-level professionals to ensure both acceptable price and highest quality of the data.